Can KemPharm's Apadaz Meet FDA Opioid Abuse Deterrent Standards?

Company cites FDA 'confusion' and indicates it will drop the product without the claim.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America